Endava plc ADR (DAVA) Beta: Monthly Comparison and Analysis

Endava plc ADR (NYSE: DAVA) closed the day trading at $36.80 down -2.34% from the previous closing price of $37.68. In other words, the price has decreased by -$0.88 from its previous closing price. On the day, 1637404 shares were traded.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Ratios:

For a better understanding of DAVA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.07 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.92. For the most recent quarter (mrq), Quick Ratio is recorded 3.33 and its Current Ratio is at 3.33. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.07.

On March 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $60.

Citigroup Downgraded its Buy to Neutral on March 01, 2024, whereas the target price for the stock was revised from $90 to $40.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DAVA now has a Market Capitalization of 2.13B and an Enterprise Value of 1.95B. As of this moment, Endava’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.38, and their Forward P/E ratio for the next fiscal year is 18.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.62 while its Price-to-Book (P/B) ratio in mrq is 1.95. Its current Enterprise Value per Revenue stands at 2.55 whereas that against EBITDA is 25.38.

Stock Price History:

Over the past 52 weeks, DAVA has reached a high of $81.06, while it has fallen to a 52-week low of $35.25. The 50-Day Moving Average of the stock is 55.10, while the 200-Day Moving Average is calculated to be 57.41.

Shares Statistics:

Over the past 3-months, DAVA traded about 536.68K shares per day on average, while over the past 10 days, DAVA traded about 767.79k shares per day. A total of 41.81M shares are outstanding, with a floating share count of 41.77M. Shares short for DAVA as of Mar 15, 2024 were 439.62k with a Short Ratio of 0.82, compared to 597.71k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.76% and a Short% of Float of 0.90%.

Earnings Estimates

Current recommendations for the stock of the company come from 10 analysts. On average, analysts expect EPS of $0.24 for the current quarter, with a high estimate of $0.35 and a low estimate of $0.21, while EPS last year was $0.76. The consensus estimate for the next quarter is $0.35, with high estimates of $0.42 and low estimates of $0.29.

Analysts are recommending an EPS of between $1.53 and $1.38 for the fiscal current year, implying an average EPS of $1.46. EPS for the following year is $2.02, with 12 analysts recommending between $2.33 and $1.64.

Revenue Estimates

A total of 13 analysts have provided revenue estimates for DAVA’s current fiscal year. The highest revenue estimate was $952.6M, while the lowest revenue estimate was $904.59M, resulting in an average revenue estimate of $922.46M. In the same quarter a year ago, actual revenue was $992.45M, down -7.10% from the average estimate. Based on 13 analysts’ estimates, the company’s revenue will be $1.01B in the next fiscal year. The high estimate is $1.15B and the low estimate is $959.68M. The average revenue growth estimate for next year is up 9.70% from the average revenue estimate for this year.

Most Popular